"particularly given the fact there has not been one adverse test...

"particularly given the fact there has not been one adverse test or trial result to date" ??

How about they have had to reformulate to reduce costs as serious indifference from industry to the original product and its seemingly obvious benefits...not at the price it seems.
How about it did NOT work with US pozzolanic cements so had to R&D a new mix...successfully it seems
How about these new products repeating the testing regimes, and " eight independent laboratory trials using regional cements and commercial mixes have commenced " In other words it didnt work very well for many, not just pozzolanics, so starting from scratch again.
How about news from Korea has been very quiet, only now we are told its because apparently Edencrete didnt work well with their local cements either so EDE now doing in-house research ?

Just because the company announcements dont cover problems, they are there as seen in the slow industry uptake, unwillingness to update progress on early trial sites on the EDE website, the need for repeating of ASTM tests, not even starting critical regulatory tests like NTPEP etc. despite several statements of intention to do so etc etc etc

Expecting a flaming...but facts are facts. I have lost a lot of $ on this story [ was holder of multimillion shares at one stage, now very disillusioned and sceptical until EDE drags itself from near 2 year lows in share price ].